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EXPERT’S CORNER: A  PERSONAL APPROACH
How  to  address a patient  with urinary  incontinence
A. Gutiérrez-González ∗
Urology  Service  of the  ‘‘Dr.  José  Eleuterio  González’’  University  Hospital  of the  Autonomous  University  of Nuevo  León,  Mexico
Received 15  December  2014;  accepted  15  December  2014
Available  online  25  February  2015
According  to  the  International  Continence  Society  (ICS), uri-
nary  incontinence  (UI) is  defined  as  the  involuntary  passing
of  urine  through  the urethra.  It is  estimated  that  over 200
million  people  in the world  suffer  from  this  condition;  a
survey  conducted  in 2002  in different  countries  found  a
UI prevalence  of  34%  in  Germany,  compared  with  15%  in
Spain.  The  elderly  have  a significant  increased  tendency
of  this  problem.  Calculations  have shown  that  11.8%  of
people  between  the  ages  of  40  and  44  may  suffer  from
this  illness,  compared  to  27.6%  of  people  between  60  and
64,  occurring  more  frequently  in females  than males  at a
5:2  ratio.
In  order  to better  understand  the  causes  of incontinence
it  is  important  to  comprehend  the  physiology  of  the  lower
urinary  tract.  The  bladder  performs  two  functions:  to  store
and  empty  urine.  In  order  to  store  urine  it is  necessary
to  have  a  competent  sphincter  and  a  distensible  detrusor
muscle.  This means  that both  the internal  sphincter  and
external  sphincter  must  have  greater  pressure  in  relation
to  the  detrusor.  As  the  bladder  is  filling  up,  propriocep-
tive  endings  of  the vegetative  system  send  impulses  toward
the  brain,  specifically  the  frontal  lobe,  where  the sense  of
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urination  becomes  conscious,  and  then  the nervous  system
sends  inhibitor  signals  to  the spinal  cord  segment  S2--S4
preventing  the  exit of  urine.  When  the  bladder  is  full,
a  disinhibition  reflex  occurs;  this disinhibition  produces  a
decrease  in the sphincter’s  pressure  and  a  detrusor  contrac-
tion,  resulting  in urination.  Urinary  incontinence  can be
caused  by  mechanical  problems  like  loss  of sphincter  pres-
sure  or  reduction  in  bladder  distensibility,  or  neurological
effects  like  those  caused  by  spinal  trauma,  diabetes  mel-
litus  or  any  other  neuropathy  which  affects  the urination
mechanism.
There  are several  types  of  UI:
Stress  incontinence  (also  known  as effort  incontinence):
When  there  is  a  sudden  change  in intra-abdominal  pres-
sure  and  the  sphincter  is  not capable  of  controlling  bladder
pressure.
Urge  incontinence  (also  known  as  hyperactive  bladder):  it
occurs  due  to  a loss  of  control  of  the inhibitor  reflex  toward
the  bladder,  producing  an urge  to  urinate.
Mixed  incontinence:  observed  in patients  with  stress  incon-
tinence  combined  with  urge  incontinence.
Overflow  incontinence:  Not  being  able to  efficiently  empty
the  bladder,  thus having  an ‘‘overflow’’  with  an  involuntary
loss  of urine.
Functional  incontinence:  in patients  with  ambulation  alter-
ations,  and who  do  not present  any  abnormality  in bladder
functioning.
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Reflex  incontinence:  in  patients  with  a  neuropathy  explain-
ing  the  loss  of  urine  control.
When  examining  a  UI  patient  we  must  ask  directed  ques-
tions,  focusing  on  the  causes  predisposing  the incontinence,
differentiate  the type  of  UI,  as  well  as  find  out the  level
of  incontinence.  For  example:  whether  or  not  the patient
uses  a  protector,  and  if so, the  type  and  number  of  pro-
tectors,  since  the extent  and  severity  of  the  UI  will  not
be  the  same  if the  patient  uses  a pad  as  a protector,  as
opposed  to  the severity  of the  patient  who  wears  a diaper.
After  the  thorough  interrogation  documenting  the  patient’s
history  and  the evolution  of  the urinary  pathology,  we  will
proceed  to  perform  physical  examinations,  corroborating
inflammatory  alterations  on the skin  around  the  genital  area
because  of  the  constant  urination.  We  must  observe  if there
are  any  ambulation  alterations  or  the impossibility  of  walk-
ing,  as  well  as  examine  the anal  tone,  if there  is  a voluntary
anus  contraction  and  if there  is  presence  of  bulbocavernosus
reflex,  this  examination  is  vital since  it will  inform  us about
the  integrity  of  the  pudendal  nerve.
Among  the  basic  studies  there  is  the urine  analysis  test
and  urine  culture,  in  order  to  rule  out  the most frequent
transitory  cause  of incontinence,  which  is  urinary  infection.
Over  the  years,  and  having  a significant  functional  blad-
der  alteration,  this  tends  to  produce  deterioration  in renal
functions  with  the possibility  of  developing  hydronephrosis
and/or  pyelonephritis.  We  should  also  consider  the possibil-
ity  of developing  lithiasis  in the  urinary  tract.  In  women,  we
must  consider  assessing  the  level of  cystocele  or  urethro-
cele,  requesting  the patient  to  push  and  observing  whether
or  not  there  is  a loss  of  urine  in the process.  Once  these
parameters  are  reviewed,  and  having  diagnosed  the type  of
UI,  we  ought  to  offer  the proper  treatment.  If we  diagnose
stress  incontinence,  we  will  assess  if the patient  is  a  candi-
date  for  pelvic floor  rehabilitation  or  a  surgical  procedure
(urethral  suspension  or  pelvic  prolapse  repair).
In  the  case  of  urge  incontinence,  by  discarding  urinary
infection  and  without  neurogenic  data  which  explains  it,
the  initial  approach  must  be  made  with  an anticholinergic
medication.  If the  response  is  positive,  continue  with  the
anticholinergic  for  a  period  of  3--4  months,  after this period
we  should  stop  the  medication  and  assess  if the vesical  func-
tion  has  normalized.  In the  case  that  there  is  no  an adequate
control  a  urodynamic  study  (the  golden  standard  for bladder
neurofunctional  evaluation)  must  be  performed.  This  study
determines  different  parameters:  intravesical,  urethral  and
abdominal  pressure.  Moreover,  an electromyography  must
be  performed,  in  the  storage  period  as  well  as  the vesical
emptying  stage,  to  try to  reproduce  the  mechanism  by  which
the  incontinence  occurs  as  a  way  to  understand  and assess
the  problem.
When  we think  a neurogenic  origin  is  the cause  of  incon-
tinence,  it  is necessary  to  assess  the patient’s  neurological
history which  may  explain  it.  If it is  not documented  it is
not  possible  to rule  out  this  possibility,  since  between  3%
and  12%  of  the patients  with  a  neurological  problem  begin
with  signs  of  UI. When  inspecting  the patient  with  a  sus-
pected  functional  bladder  alteration,  the  urodynamic  study
will  help  with  the diagnosis  of  the  type  of  neurogenic  blad-
der,  evaluating  the  possibility  of upper  urinary  tract  damage.
Subsequent  urodynamic  studies  will  reveal  whether  or  not
there  was  a response  to  treatment.
There  are  a variety  of  UI  treatments:  (a)  medical,  (b)
rehabilitation  and  (c)  surgical.
(a)  Medical  treatments  include  the use  of  anticholinergics
like  oxybutynin  vs  tolterodine.  Currently,  beta-3  adreno-
ceptors,  like  Mirabegron  (which  is  not  sold  in Mexico)
are  used  to  reduce  the detrusor  muscle  pressure  and
increase  vesical  capacity.  Tricyclic  antidepressants  like
imipramine  help  improve  the  contraction  strength  of
the  external  sphincter  and reduce  stress  urinary  incon-
tinence  periods.
(b)  Rehabilitation  treatments  using  Kegel  exercises,  where
the  patient  is  shown  how  to  contract  and  strengthen  the
perineum  musculature.  These  are useful  in  the  handling
of  stress  incontinence  in women  with  pelvic  floor  pro-
lapse,  as  well  as  in prostatectomized  men. It has  been
shown  that  only  40%  of the  patients  perform  the  exer-
cises  correctly,  most  contract  the abdomen  instead  of
the perineum  which  worsens  the symptoms.  With  proper
guidance  and  training,  we  can  help  patients  perform
these  exercises  correctly.  Perineum  electrostimulation
can  also  be used  in order  to  improve  muscle  tone,  or
posterior  tibial nerve  stimulation  for a better  managing
of  urge  incontinence.
(c)  Surgical  treatments  include  the  application  of  botulinum
toxin  (botox)  at the  sphincter  level to  reduce  its  pres-
sure  in patients  with  extremely  high  pressures.  It  is  also
used with  patients  who  do not  respond  adequately  to
anticholinergics.  This  toxin  contributes  to  the  reduction
of  intravesical  pressure  and  improves  storage  capa-
bilities.  An  anesthetic  sedation  is  necessary  for  the
application  of botox,  and  the  introduction  of  a  cysto-
scope  to  infiltrate  the  muscular  layer  of the bladder.
In some  UI  patients  who  do  not  respond  adequately  or
have  a severe  incontinence  level,  the use  of  urethral
tapes  and  slings at a urethral level  may  help  control
involuntary  loss  of  urine. Patients  who  do not improve
their  vesical  capacity  with  any  of  these  interventions  can
undergo  an augmentation  cystoplasty,  which  consists  of
the  use  of  an  intestinal  patch  to  increase  distention  sur-
face,  thus  increasing  the  capacity  and reducing  vesical
pressure,  which  would be the last  line  in the manage-
ment  of  capacity  and  intravesical  improvement.  Those
patients  with  an  intrinsic  sphincter  deficiency  can  be
closed  with  a  sling  or  tape on  the  urethra  to  produce
an  obstruction,  which  will  have to  be managed  with
intermittent  catheterization.  Also,  there  is  the artifi-
cial  sphincter,  a  surgical  procedure  with  application  of
a  prosthesis  with  a urethral  cuff.  When  pumped  (at
scrotum  level or  in the  vulva’s  labia  majora),  the cuff
empties  and  the  release  of  urine  occurs.
Neuromodulation  consists  of placing  electrodes  in the
sacral  nerve  roots,  which go to  an internal  computer  sys-
tem,  which  regulates  and  modulates  the stimuli  which occur
in  the  bladder,  improving  urinary  storage  and  emptying,  as
well  as  controlling  the possible  pain  that  the  patient  may
have.
Once  we  have  assessed  the patient,  made  the  correct
diagnosis  and offered  the  proper treatment,  it  is  important
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to  give  follow-up  to  prevent  complications,  improve  self-
esteem  and  avoid  social  stigmatization.
After  ruling  out  correctable  causes  like urinary  infection,
vesicoureteral  reflux  and  hydronephrosis,  if the  patient’s
symptoms  persist,  it is  important  to  refer  him/her  to  a spe-
cialist  with  experience  in the  management  and  treatment  of
these  type  of  pathology,  considering  that  the main  cause  of
morbi-mortality  in patients  with  neurogenic  bladder  is  renal
failure.
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